Paper Review Records
全部论文审稿周期
27 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
53
天
Drug–Drug Interaction Assessment of WXFL10203614 With Rifampicin, Itraconazole and Metformin: A Three‐Cohort Phase I Study
作者
Jinmei Zhou; Mengshuang Gao; Daolei Zhou; Zhiwei Zhang; Huan Zhang; Yu Sun; Huan Zhou展开收起
作者单位
1. School of Pharmacy Bengbu Medical University Bengbu Anhui China; 2. Clinical Trial Center The First Affiliated Hospital of Bengbu Medical University Bengbu Anhui China; 3. College of Laboratory Medicine Bengbu Medical University Bengbu Anhui China; 4. Zhuohe Pharmaceutical Group Co., Ltd. Wuxi City Jiangsu Province China展开收起
194
天
Comparability of Pharmacokinetics, Safety, and Tolerability of Canakinumab Administration With One Injection (200 mg) of Pre‐Filled Syringe or Auto‐Injector Versus Two Injections (150 and 50 mg) of Pre‐Filled Syringe in Healthy Subjects
作者
Abhijit Chakraborty; Anshu Marathe; Jong Bong Lee; Kari Wiedinger; Britta Zehnpfennig; Carole Schuhler; Simantini Eddy; Michelle Quinlan展开收起
作者单位
1. Novartis Institutes for Biomedical Research East Hanover NJ USA; 2. Insmed NJ USA; 3. Novartis Pharma AG Basel Switzerland; 4. Novartis Pharmaceuticals Corporation East Hanover NJ USA展开收起
145
天
A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants
作者
Joseph F. Grippo; Anja Pfaff; Zhongli Xu; Isabell Otto; Claus Thielert; Mihaly Imre; Rui Liu; Wantanee Phuapradit; Yazhong Pei; Cuie Chen; Maria Habel; Renfeng Guo; Camilla Chong展开收起
作者单位
1. InflaRx GmbH Jena Germany; 2. InflaRx Pharmaceuticals, Inc. Ann Arbor MI USA展开收起
159
天
A Bioequivalence Study of Two Formulations of Enzalutamide Soft Capsules in Healthy Chinese Male Subjects
作者
Jianxin Wang; Kai Gu; Mingxuan Zhang; Miao Yu; Pei Zhao; Jing Yu; Xiaohong Guo; Yating Bai; Jie Liu; Xiaoli Wang; Xiaolai Yang展开收起
作者单位
1. School of pharmacy Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China; 2. Department of Pharmacy Gansu Provincial People's Hospital Lanzhou Gansu Province China; 3. Faculty of Health Sciences (FHS) University of Macau Taipa Macau SAR China展开收起
2
天
55
天
Fed–Fasted Differences in Clindamycin Hydrochloride Capsule Pharmacokinetics: A Pooled Analysis of Publicly Available China CDE Regulatory Summaries
作者
Rui Li; Deshuang Yang; Lang Zhao; Zhengyi Cao; Xiaoyu Li; Mengxi Yang展开收起
作者单位
1. Department of Geriatrics China‐Japan Friendship Hospital Chaoyang District Beijing China; 2. Department of Cardiology of Integrated traditional Chinese and Western Medicine China‐Japan Friendship Hospital Chaoyang District Beijing China; 3. Department of Emergency China‐Japan Friendship Hospital Chaoyang District Beijing China; 4. Department of Hematology China‐Japan Friendship Hospital Chaoyang District Beijing China; 5. Jinan Academician Workstation, Shandong Academy of Chinese Medicine, Lixia District Jinan City Shandong Province China展开收起
FAQ
Clinical Pharmacology in Drug Development审稿要多久?
截至2026-11-17,CrushSCI 收录了 Clinical Pharmacology in Drug Development 的 27 篇完整审稿记录。最快一篇从收稿到录用用了 2 天(When Clinical Pharmacology Cannot Wait for Complete Data: Reflections Following the 2026 ACCP Annual Meeting,2026-09-28 收稿,2026-09-30 录用),最慢一篇用了 296 天;平均 125.7 天,中位数 111 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
